Senti Biosciences, Inc.SNTINASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank67
3Y CAGR-1.5%
5Y CAGR+20.0%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.5%/yr
Annual compound
5Y CAGR
+20.0%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.5x
Strong expansion
Streak
1 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $62.47M | +2.3% |
| 2024 | $61.04M | -35.5% |
| 2023 | $94.70M | +44.9% |
| 2022 | $65.37M | +53.0% |
| 2021 | $42.74M | +70.3% |
| 2020 | $25.09M | +239.4% |
| 2019 | $7.39M | - |